Clinical Trial Update: IV Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating intravenous oxytocin for postoperative pain relief after minimally invasive hysterectomy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain Postoperative

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Pain, Postoperative, Analgesia | Phase 4 | Status: WITHDRAWN